Back to all Programs

Register here

Related Materials

Past event

International Workshop on HBV Cure 2024

Viral Hepatitis and Liver Disease

International Workshop on HBV Cure 2024 - Promo Video

Viral Hepatitis and Liver Disease

Prospects for Gene Editing in CHB Cure Regimens - Fabien Zoulim, MD, PhD

Viral Hepatitis and Liver Disease

Strategies and Potential for siRNA + ASO Combinations - Dickens Theodore, MD, MPH

Viral Hepatitis and Liver Disease

Next Generation Tests for HBcAg and HBcrAg - Increased Sensitivity and Utility? - Mark Sulkowski, MD

Viral Hepatitis and Liver Disease

Imdusiran Combinations Achieving HBsAg Loss - Karen Sims, MD, PhD

Viral Hepatitis and Liver Disease

Efficacy of Cams across Patient Cohorts: HBeAg+ vs. HBeAg- - Tse-I Lin, D.Phil

Viral Hepatitis and Liver Disease

Sustainability of HBsAg Loss After Treatment: Functional Cure - Harry Janssen, MD, PhD

Viral Hepatitis and Liver Disease

Additive Benefit of Mab in siRNA + IFN-α Combinations - Carey Hwang, MD, PhD

Viral Hepatitis and Liver Disease

Immunological Editing to Drive HBsAg Production - Adam Gehring, PhD

Viral Hepatitis and Liver Disease

RNA Interference Combined with Immune Modulation - Ed Gane, MBChB, MD, FRACP, FAASLD, MNZM

Viral Hepatitis and Liver Disease

Insights from Intrahepatic Analysis in Clinical Trials for Chronic Hepatitis B -Jordan Feld, MD, MPH

Viral Hepatitis and Liver Disease

Intrahepatic Landscape in the Delta-Infected, Bulevirtide-Treated Liver - Maura Dandri, PhD

Viral Hepatitis and Liver Disease

Therapeutic Vaccine with Novel Checkpoint Inhibition - Sue Currie, PhD